Expert Doctors Ltd Filleted accounts for Companies House (small and micro)

EXPERT DOCTORS LTD - Company Information

0 false false false false false false false false false true false false false false false false No description of principal activity 2021-04-01 Sage Accounts Production Advanced 2021 - FRS102_2021 xbrli:pure xbrli:shares iso4217:GBP 07627624 2021-04-01 2022-03-31 07627624 2022-03-31 07627624 2021-03-31 07627624 2021-03-31 07627624 core:PlantMachinery 2021-04-01 2022-03-31 07627624 core:FurnitureFittings 2021-04-01 2022-03-31 07627624 bus:Director1 2021-04-01 2022-03-31 07627624 core:PlantMachinery 2021-03-31 07627624 core:FurnitureFittings 2021-03-31 07627624 core:PlantMachinery 2022-03-31 07627624 core:FurnitureFittings 2022-03-31 07627624 core:WithinOneYear 2022-03-31 07627624 core:WithinOneYear 2021-03-31 07627624 core:ShareCapital 2022-03-31 07627624 core:ShareCapital 2021-03-31 07627624 core:RetainedEarningsAccumulatedLosses 2022-03-31 07627624 core:RetainedEarningsAccumulatedLosses 2021-03-31 07627624 core:PlantMachinery 2021-03-31 07627624 core:FurnitureFittings 2021-03-31 07627624 bus:Director1 2021-03-31 07627624 bus:Director1 2022-03-31 07627624 bus:Director1 2020-03-31 07627624 bus:Director1 2021-03-31 07627624 bus:Director1 2020-04-01 2021-03-31 07627624 bus:SmallEntities 2021-04-01 2022-03-31 07627624 bus:AuditExemptWithAccountantsReport 2021-04-01 2022-03-31 07627624 bus:FullAccounts 2021-04-01 2022-03-31 07627624 bus:SmallCompaniesRegimeForAccounts 2021-04-01 2022-03-31 07627624 bus:PrivateLimitedCompanyLtd 2021-04-01 2022-03-31

COMPANY REGISTRATION NUMBER: 07627624

Expert Doctors Ltd

Filleted Unaudited Financial Statements

31 March 2022

Expert Doctors Ltd

Statement of Financial Position

31 March 2022

	2022	2021
Note	£	£

Fixed assets

Tangible assets	4	10,643	12,521

Current assets

Debtors	5	1,033,156	493,186
Cash at bank and in hand		954,477	504,564
		------------	---------
		1,987,633	997,750

Creditors: amounts falling due within one year	6	214,425	54,402
		------------	---------
Net current assets		1,773,208	943,348
		------------	---------
Total assets less current liabilities		1,783,851	955,869
		------------	---------
Net assets		1,783,851	955,869
		------------	---------

Capital and reserves

Called up share capital	4	4
Profit and loss account	1,783,847	955,865
	------------	---------
Shareholders funds	1,783,851	955,869
	------------	---------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.

For the year ending 31 March 2022 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;

- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

Expert Doctors Ltd

Statement of Financial Position (continued)

31 March 2022

These financial statements were approved by the board of directors and authorised for issue on 31 March 2023 , and are signed on behalf of the board by:

W Hussain

Director

Company registration number: 07627624

Expert Doctors Ltd

Notes to the Financial Statements

Year ended 31 March 2022

1. General information

The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 10 Cliff Parade, Wakefield, West Yorkshire, WF1 2TA.

2. Statement of compliance

These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The financial statements are prepared in sterling, which is the functional currency of the entity.

Revenue recognition

Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Income tax

The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.

Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

Plant and machinery	-	15% reducing balance
Fixtures and fittings	-	15% reducing balance

Impairment of fixed assets

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.

Financial instruments

The company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors and loans fron banks.

4. Tangible assets

	Plant and machinery	Fixtures and fittings	Total
	£	£	£
Cost
At 1 April 2021 and 31 March 2022	24,588	3,735	28,323
	--------	-------	--------
Depreciation
At 1 April 2021	15,240	562	15,802
Charge for the year	1,402	476	1,878
	--------	-------	--------
At 31 March 2022	16,642	1,038	17,680
	--------	-------	--------
Carrying amount
At 31 March 2022	7,946	2,697	10,643
	--------	-------	--------
At 31 March 2021	9,348	3,173	12,521
	--------	-------	--------

5. Debtors

	2022	2021
	£	£
Trade debtors	295,132	187,000
Other debtors	738,024	306,186
	------------	---------
	1,033,156	493,186
	------------	---------

6. Creditors: amounts falling due within one year

	2022	2021
	£	£
Social security and other taxes	196,036	52,762
Other creditors	18,389	1,640
	---------	--------
	214,425	54,402
	---------	--------

7. Directors' advances, credits and guarantees

During the year the directors entered into the following advances and credits with the company:

	2022
	Balance brought forward	Advances/ (credits) to the directors	Balance outstanding
	£	£	£
W Hussain	( 764)	( 15,153)	( 15,917)
	----	--------	--------

	2021
	Balance brought forward	Advances/ (credits) to the directors	Balance outstanding
	£	£	£
W Hussain	( 5,448)	4,684	( 764)
	-------	-------	----